← Eichor
Study identifier: NCT05570448 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Anti-Reflux Endoscopic TX Using APC (AREA) in GERD Patients: (The AREA Study)

Condition: Gastro Esophageal Reflux  ·  Sponsor: Midwest Veterans' Biomedical Research Foundation

PhaseNA
Planned participants36
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

This will be a randomized clinical trial examining the efficacy and safety of ARAT (intervention group) in patients with chronic GERD symptoms (typical symptoms of GERD, i.e. heartburn or acid reflux/regurgitation at least twice a week) for the last 6 months. Patients must have a positive pH test and a negative manometry (no treatment) procedure.

This description comes directly from the study's public registry record.

Talk to the study team

April Higbee, BSN  ·  816-861-4700  ·  april.higbee@va.gov

Carlissa Campbell, MS  ·  816-861-4700  ·  Carlissa.Campbell@va.gov

Always discuss trial participation with your own doctor first.

Locations (1)

Kansas City VA HospitalKansas City, Missouri, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05570448